U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
114421114421Test Efficacy of Biodegradable and Permanent Limus-Eluting StentsActive, not recruitingNo Results AvailableCoronary Heart DiseaseDevice: Nobori® (Biodegradable polymer limus-eluting stents)|Device: Xience-V® (Permanent polymer limus-eluting stent)https://ClinicalTrials.gov/show/NCT01068106
114422114422The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary SyndromeRecruitingNo Results AvailableCoronary Artery DiseaseDrug: Ezetimibehttps://ClinicalTrials.gov/show/NCT01068093
114423114423Involvement of FFA Metabolism and Insulin Resistance in Cardiac DeathCompletedNo Results AvailableKidney Disease|Coronary Artery Disease|Hemodialysishttps://ClinicalTrials.gov/show/NCT01068080
114424114424Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant RecipientsRecruitingNo Results AvailableRenal TransplantationOther: drug (tacrolimus and SchE) and genetics|Drug: tacrolimushttps://ClinicalTrials.gov/show/NCT01068067
114425114425Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)CompletedNo Results AvailableKeratoconjunctivitis, VernalDrug: tacrolimus|Drug: cyclosporinshttps://ClinicalTrials.gov/show/NCT01068054
114426114426Effects of PH3 in Diabetic NephropathyActive, not recruitingNo Results AvailableDiabetic NephropathyDrug: PH3https://ClinicalTrials.gov/show/NCT01068041
114427114427Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741CompletedNo Results AvailableHealthyDrug: ORM-12741|Drug: Placebo for ORM-12741https://ClinicalTrials.gov/show/NCT01068028
114428114428(Men Who Have Sex With Men) MSM Community Intervention TrialActive, not recruitingNo Results AvailableHIV|Syphilis|Herpesvirus 2, HumanOther: behavior intervention and male circumcisionhttps://ClinicalTrials.gov/show/NCT01068015
114429114429Cardiovascular an Echocardiographic Assessment in Hypertension During PregnancyRecruitingNo Results AvailablePregnancyhttps://ClinicalTrials.gov/show/NCT01068002
114430114430Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerTerminatedNo Results AvailableChemotherapy|Breast Cancer, MetastaticDrug: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)https://ClinicalTrials.gov/show/NCT01067989
114431114431Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRICompletedHas ResultsBreast Cancer|Diagnostic ImagingDrug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)https://ClinicalTrials.gov/show/NCT01067976
114432114432Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney DiseaseTerminatedNo Results AvailableDiabetes Mellitus, Type 2|Renal Insufficiency, ChronicBehavioral: Computer assisted education and motivational interviewing.|Behavioral: Group talks/social chathttps://ClinicalTrials.gov/show/NCT01067963
114433114433Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage StudyRecruitingNo Results AvailableType 1 DiabetesProcedure: Isolated Pancreas Transplant|Drug: Intensive Insulin Therapyhttps://ClinicalTrials.gov/show/NCT01067950
114434114434Study for a Rational Management of Appendicitis in ChildrenCompletedNo Results AvailableAppendicitisProcedure: appendectomyhttps://ClinicalTrials.gov/show/NCT01067937
114435114435Motivational Interviewing to Promote Maintenance of Physical Activity in People With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesBehavioral: Motivational interviewinghttps://ClinicalTrials.gov/show/NCT01067924
114436114436Optimizing Dietary Fatty Acids to Lower Metabolic Risk Factors Among CanadiansSuspendedNo Results AvailablePostprandial LipaemiaDietary Supplement: Butter and Vegetable oils from soy, flaxseed, high oleic safflower and canola|Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butter|Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butter|Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butterhttps://ClinicalTrials.gov/show/NCT01067911
114437114437A Study on Oral Vitamin D MegadosesCompletedNo Results AvailableHypovitaminosis DDietary Supplement: vitamin D3 (cholecalciferol)|Other: olive oil|Dietary Supplement: calcium carbonatehttps://ClinicalTrials.gov/show/NCT01067898
114438114438A Post-market Registry of the MARIS-stent (Invatec) Implanted in the Superficial Femoral ArteryCompletedNo Results AvailablePeripheral Artery DiseaseDevice: MARIS-stent (Invatec)https://ClinicalTrials.gov/show/NCT01067885
114439114439A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)TerminatedNo Results AvailableAcute Heart FailureDrug: Cinaciguat (BAY58-2667)|Drug: Cinaciguat (BAY58-2667)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01067859
114440114440Cognitive Enhancement and Relapse Prevention in Cocaine AddictionCompletedHas ResultsCocaine AddictionDrug: Seromycin (D-cycloserine, DCS)|Drug: Placebo|Behavioral: Computerized Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT01067846
114441114441Phase 2 Study of Oral K201 for Prevention of AF RecurrenceTerminatedNo Results AvailableAtrial FibrillationDrug: K201 Tablet|Drug: Placebo Tablethttps://ClinicalTrials.gov/show/NCT01067833
114442114442ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression EvaluationCompletedNo Results AvailableCoronary Artery DiseaseDrug: RVX000222|Drug: Placebo RVX000222https://ClinicalTrials.gov/show/NCT01067820
114443114443Proellex Pharmacokinetics Bridging StudyCompletedNo Results AvailableHealthyDrug: 25 mg Proellex|Drug: 25 mg Proellex|Drug: 25 mg Proellex|Drug: 50 mg Proellexhttps://ClinicalTrials.gov/show/NCT01067807
114444114444Chemotherapy in Treating Patients With Lung CancerCompletedNo Results AvailableNon Small Cell Lung CancerDrug: Any platinum-based doublet chemotherapyhttps://ClinicalTrials.gov/show/NCT01067794
114445114445Gender-Stratified Safety and Immunogenicity StudyCompletedHas ResultsDiarrheaBiological: Heat-Labile Enterotoxin of E. coli (LT)|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01067781
114446114446Reduction of Catheter-associated Urinary Tract Infection With a Daily Nursing Review of the IndicationCompletedHas ResultsUrinary Tract Infections|Urinary Tract; AccessoryOther: Daily reviewhttps://ClinicalTrials.gov/show/NCT01067768
114447114447Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) SystemRecruitingNo Results AvailableLung NeoplasmDevice: LungPoint Virtual Bronchoscopic Navigation (computer-assisted image-guided bronchoscopic navigation)https://ClinicalTrials.gov/show/NCT01067755
114448114448The Natural History of Mucolipidosis Type IVRecruitingNo Results AvailableMucolipidosis Type IVhttps://ClinicalTrials.gov/show/NCT01067742
114449114449A Postmarket Randomized Study of the Treatment of Superficial Partial-Thickness Burns Using Two DressingsTerminatedNo Results AvailableBurnsDevice: AWBAT Wound Dressing|Device: AWBAT™, Biobrane®https://ClinicalTrials.gov/show/NCT01067729
114450114450Performance and Acceptability of VSS-RCompletedHas ResultsRefractive ErrorDevice: STAR S4IR LASIK with VSS-R ablation profilehttps://ClinicalTrials.gov/show/NCT01067716

* Görseller ve İçerik tekif hakkına sahip olabilir